California Life Sciences announces formal collaboration with Life Science NationBack
November 7, 2022
SAN FRANCICSO, Calif, — California Life Sciences (CLS), the state’s most impactful life sciences membership organization, announced today that it has entered into a collaboration with Life Science Nation to offer distinct benefits to CLS members that support their fundraising efforts and help them connect with Seed to Series B investors, channel partners, and licensing collaborators at RESI San Francisco, Jan 10-12, 2023.
CLS is expanding its innovation and entrepreneurship portfolio by offering and creating resources to help entrepreneurs and startups thrive. To better assist our early-stage members maximize their fundraising efforts and to find partners who are a fit for their technology and stage of development, CLS members will receive exclusive discounts to attend RESI San Francisco at JPM (January 10-12).
- CLS-exclusive discount codes for all CLS members currently raising a Seed to Series A/B
- CLS Innovation Track: CLS will offer financial support for selected eight (8) companies to participate in the Innovator’s Pitch Challenge.
- Webinars and education sessions including partnering tutorials and fundraising bootcamps for attending CLS members
“RESI is a unique and powerful platform with a diverse portfolio of life science investors, including family offices, as well as industry and licensing partners helping to accelerate innovation across early-stage life science and healthcare,” said Sibylle Hauser, executive director of Innovation and Entrepreneurship at CLS. “We are excited to offer start-ups an unprecedented level of exposure to US and global investors as well as licensing partners for therapeutics, devices, diagnostics, tools, and digital health at the biggest investment & partnering week in life sciences.”
CLS is known for its premier FAST advisory program. For the past 9 years, more than 100 companies have benefited from the customized 12-week advisory program to support their scaling efforts in different stages of early preclinical development.
“Dennis Ford, Founder & CEO of Life Science Nation and Creator of the RESI Conference Series, is pleased to announce a first-of-its-kind collaboration with California Life Sciences as a strategic global tech hub partner. The opportunity here is to showcase the technology assets that are coming from one of the top hubs in the world and make it easier for global capital investors and licensing partners to connect with early-stage scientist-entrepreneurs and fundraising CEOs.”
For more information about RESI at JPM: https://resiconference.com/
To learn more about the different opportunities to gain exposure at JPM week 2023, please email [email protected]